News KPC Pharmaceuticals,Inc.

Equities

600422

CNE0000015P8

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-07-14 pm EDT			5-day change	1st Jan Change
16.99 ^CNY	-0.18%		-1.96%	-18.55%

Jun. 08	KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion.	CI
Apr. 19	KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

KPC Pharmaceuticals,Inc agreed to acquire 51% stake in China Resources Kunming Shenghuo Pharmaceutical Co., Ltd. from China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. for CNY 1.8 billion.	Jun. 07	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Kunyao Group Receives Clinical Trial Approval for FMF Drug	Apr. 16	MT
KPC Pharmaceuticals,Inc Proposes Cash Dividend	Mar. 21	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
KPC Pharmaceuticals,Inc Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
KPC Pharmaceuticals’ Antimalarial Drug Passes WHO Prequalification	23-10-13	MT
KPC Pharmaceuticals' Attributable Profit Rises 3.1%; Shares Slip 4%	23-08-29	MT
KPC Pharmaceuticals,Inc Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
KPC Pharmaceuticals' Q1 Net Profit Jumps; Shares Rise 7%	23-04-27	MT
KPC Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27	CI
KPC Pharma’s Shingles Drug Added to China’s Medical Insurance Catalog	23-01-20	MT
KPC Pharma to Hold Phase II Clinical Trial of Stroke Drug	23-01-20	MT
China Resources Pharmaceutical Completes Transfer of KPC Pharmaceutical Shares to Unit	23-01-02	MT
KPC Pharmaceuticals CFO Steps Down	23-01-02	MT
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. completed the acquisition of a 28% stake in KPC Pharmaceuticals, Inc. from Hofon Pharmaceuticals Co.,Ltd. and Holley Group Company Limited.	22-12-29	CI
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-24	CI
KPC Pharmaceuticals Unit Receives Marketing Authorization of Angong Niuhuang Pills; Shares Jump 7%	22-10-21	MT
KPC Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-15	CI
Chinese Shares Rebound; KPC Pharma Rallies 10% on CR Sanjiu’s $431 Million Stake Purchase	22-05-10	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News KPC Pharmaceuticals,Inc.

Equities

600422

CNE0000015P8

Summary

Filters